Tenon Medical, Inc. financial data

Symbol
TNON, TNONW on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
104 Cooper Ct., Los Gatos, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 26, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 275 % +92.5%
Quick Ratio 22.9 % +80.2%
Debt-to-equity 98.2 % -73.2%
Return On Equity -294 % +68.6%
Return On Assets -148 % +25.9%
Operating Margin -420 % +21.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.58M shares +49.9%
Common Stock, Shares, Outstanding 3.14M shares +866%
Entity Public Float 1.83M USD -62.6%
Common Stock, Value, Issued 3K USD 0%
Weighted Average Number of Shares Outstanding, Basic 1.21K shares +435%
Weighted Average Number of Shares Outstanding, Diluted 1.21K shares +435%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.28M USD +11.9%
Cost of Revenue 1.57M USD -7.17%
Research and Development Expense 2.6M USD -17.7%
Selling and Marketing Expense 5.11M USD -24.6%
General and Administrative Expense 7.77M USD +10.5%
Operating Income (Loss) -13.8M USD +12.5%
Nonoperating Income (Expense) 93K USD -36.3%
Net Income (Loss) Attributable to Parent -13.7M USD +12.2%
Earnings Per Share, Basic -11.3 USD/shares +83.6%
Earnings Per Share, Diluted -11.3 USD/shares +83.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.54M USD +169%
Accounts Receivable, after Allowance for Credit Loss, Current 863K USD +66.6%
Inventory, Net 606K USD +9.39%
Assets, Current 8.21M USD +111%
Property, Plant and Equipment, Net 752K USD -21.7%
Operating Lease, Right-of-Use Asset 399K USD -38.2%
Assets 9.84M USD +55.1%
Accounts Payable, Current 369K USD -14.8%
Employee-related Liabilities, Current 482K USD
Accrued Liabilities, Current 910K USD +12.6%
Liabilities, Current 1.87M USD -40.5%
Operating Lease, Liability, Noncurrent 141K USD -67.1%
Liabilities 3.87M USD -30.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -46K USD +54%
Retained Earnings (Accumulated Deficit) -68.7M USD -24.8%
Stockholders' Equity Attributable to Parent 5.97M USD +667%
Liabilities and Equity 9.84M USD +55.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.34M USD +34.6%
Net Cash Provided by (Used in) Financing Activities 4.37M USD
Net Cash Provided by (Used in) Investing Activities -119K USD -103%
Common Stock, Shares Authorized 130M shares 0%
Common Stock, Shares, Issued 3.14M shares +866%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.96M USD +86.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.54M USD +169%
Deferred Tax Assets, Valuation Allowance 13.8M USD +11.4%
Deferred Tax Assets, Gross 14M USD +10.7%
Operating Lease, Liability 428K USD -37.4%
Depreciation 105K USD +128%
Payments to Acquire Property, Plant, and Equipment 84K USD -34.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -13.6M USD +12.2%
Lessee, Operating Lease, Liability, to be Paid 455K USD -39.8%
Property, Plant and Equipment, Gross 1.42M USD +15.1%
Operating Lease, Liability, Current 287K USD +12.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 144K USD -53.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 311K USD +2.98%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 27K USD -62.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 144K USD -53.5%
Deferred Tax Assets, Operating Loss Carryforwards 10.8M USD +13.7%
Unrecognized Tax Benefits 44K USD -44.3%
Lessee, Operating Lease, Liability, to be Paid, Year Four 144K USD 0%
Operating Lease, Payments 74K USD +2.78%
Additional Paid in Capital 71M USD +27%
Depreciation, Depletion and Amortization 100K USD +300%
Deferred Tax Assets, Net of Valuation Allowance 108K USD -39.3%
Share-based Payment Arrangement, Expense 3.85M USD -7.24%
Interest Expense 34K USD